NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti‐CD3 antibody

E-ISSN： 1521-4141|41|7|1832-1842

ISSN： 0014-2980

Source： EUROPEAN JOURNAL OF IMMUNOLOGY, Vol.41, Iss.7, 2011-07, pp. : 1832-1842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A clonal model for human CD8+ regulatory T cells: Unrestricted contact‐dependent killing of activated CD4+ T cells

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 42, Iss. 1, 2012-01 ,pp. : 69-79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence for eomesodermin‐expressing innate‐like CD8+ KIR/NKG2A+ T cells in human adults and cord blood samples

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 7, 2015-07 ,pp. : 1926-1933

John Wiley & Sons Inc

Access to resources Recommend Favorite

The natural killer–activating receptor, NKG2D, on CD3+CD8+ T cells plays a critical role in identifying and killing autologous myeloma cells

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1515-1521

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral anti‐CD3 immunotherapy for HCV‐nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase‐2a placebo‐controlled trial

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 8, 2015-08 ,pp. : 651-657

John Wiley & Sons Inc

Access to resources Recommend Favorite

Functional Anti‐CD94/NKG2A and Anti‐CD94/NKG2C Autoantibodies in Patients With Systemic Lupus Erythematosus

ARTHRITIS & RHEUMATOLOGY, Vol. 67, Iss. 4, 2015-04 ,pp. : 1000-1011

John Wiley & Sons Inc

Access to resources Recommend Favorite